Cargando…
NPC-26 kills human colorectal cancer cells via activating AMPK signaling
NPC-26 is novel mitochondrion-interfering compound. The current study tested its potential effect against colorectal cancer (CRC) cells. We demonstrated that NPC-26 induced potent anti-proliferative and cytotoxic activities against CRC cell lines (HCT-116, DLD-1 and HT-29). Activation of AMP-activat...
Autores principales: | Zhao, Zhen, Feng, Li, Wang, Jiqin, Cheng, Deshan, Liu, Mei, Ling, Meirong, Xu, Weiping, Sun, Keyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392330/ https://www.ncbi.nlm.nih.gov/pubmed/28407688 http://dx.doi.org/10.18632/oncotarget.15436 |
Ejemplares similares
-
CC-223 blocks mTORC1/C2 activation and inhibits human hepatocellular carcinoma cells in vitro and in vivo
por: Xie, Zichen, et al.
Publicado: (2017) -
Bioinformatics-based study to detect chemical compounds that show potential as treatments for pulmonary thromboembolism
por: Sun, Keyu, et al.
Publicado: (2019) -
The NPC, in detail
por: Robinson, Richard
Publicado: (2007) -
Loss of ARID1A promotes proliferation, migration and invasion via the Akt signaling pathway in NPC
por: Yang, Yang, et al.
Publicado: (2019) -
Targeted Inactivation of GPR26 Leads to Hyperphagia and Adiposity by Activating AMPK in the Hypothalamus
por: Chen, Daohong, et al.
Publicado: (2012)